We found that PLK1 expression was increased with TP53 mutant status, indicating that cancer occurrence and development gained from a drive from synergistic function between TP53 mutation and PLK1 activity in lung adenocarcinoma and lung squamous cell carcinoma. This evidence concerns the gene PLK1 and lung adenocarcinoma.